主管单位:中华人民共和国
国家卫生健康委员会
主办单位:中国医师协会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Jia Xiaoyue1 Sun Qianmei2 Zhang Liping1 Li Yanchun3 Yang Jie1 Zuo Li4
单位:1北京积水潭医院肾内科100035;2首都医科大学附属北京朝阳医院综合科100020;3首都医科大学附属北京朝阳医院肾内科100020;4北京大学人民医院肾内科100044
英文单位:1Department of Nephrology Beijing Jishuitan Hospital Beijing 100035 China; 2Department of General Medicine Beijing Chao-yang Hospital Capital Medical University Beijing 100020 China; 3Department of Nephrology Beijing Chao-yang Hospital Capital Medical University Beijing 100020 China; 4Department of Nephrology Peking University People’s Hospital Beijing 100044 China
关键词:维持性血液透析;颈总动脉内膜中层厚度;脉搏波传导速度;预后
英文关键词:Maintenancehemodialysis;Commoncarotidarteryintima-mediathickness;Pulsewavevelocity;Prognosis
目的 探讨颈总动脉内膜中层厚度(CCA-IMT)和颈动脉-股动脉脉搏波传导速度(cfPWV)对维持性血液透析(MHD)患者远期预后的影响。方法 选取2014年1—3月于北京积水潭医院和首都医科大学附属北京朝阳医院治疗的91例MHD患者的临床及随访资料进行回顾性分析。收集患者的基线资料,随访前检测CCA-IMT和cfPWV。随访85个月,记录MHD患者的生存情况,分为存活组(36例)和死亡组(55例);根据CCA-IMT将患者分为CCA-IMT增厚组(43例,≥0.9 mm)和CCA-IMT正常组(48例,<0.9 mm);根据cfPWV将患者分为cfPWV升高组(37例,≥12 m/s)和cfPWV正常组(54例,<12 m/s)。分析MHD患者全因死亡和心脑血管事件死亡的危险因素。结果 死亡组年龄、糖尿病肾病比例、高敏C反应蛋白水平、血清铁蛋白水平、CCA-IMT均高于/大于生存组(均P<0.05)。Kaplan-Meier生存曲线分析结果显示,CCA-IMT增厚组全因死亡率和心脑血管事件死亡率均高于CCA-IMT正常组(均Log-rank P<0.001);cfPWV升高组全因死亡率和心脑血管事件死亡率均高于cfPWV正常组(Log-rank P=0.017、0.025)。多因素Cox回归分析结果显示,年龄(风险比=1.035,95%置信区间:1.005~1.066,P=0.023)、糖尿病肾病(风险比=3.497,95%置信区间:1.886~6.485,P<0.001)、CCA-IMT≥0.9 mm(风险比=2.077,95%置信区间:1.114~3.872,P=0.021)、SF(风险比=1.001,95%置信区间:1.000~1.002,P=0.019)是MHD患者全因死亡的独立危险因素;糖尿病肾病(风险比=2.632,95%置信区间:1.202~5.765,P=0.016)、CCA-IMT≥0.9 mm(风险比=6.261,95%置信区间:2.611~15.010,P<0.001)、cfPWV≥12 m/s(风险比=2.644,95%置信区间:1.253~5.577,P=0.011)是MHD患者心脑血管事件死亡的独立危险因素。结论 CCA-IMT和cfPWV增加是MHD患者远期全因死亡和心脑血管事件死亡的独立危险因素。
Objective To explore the impact of common carotid artery intima-media thickness (CCA-IMT) and carotid-femoral pulse wave velocity(cfPWV) on the long-term outcome in maintenance hemodialysis(MHD)patients. Methods Clinical and follow-up data of 91 patients who underwent MHD in Beijing Jishuitan Hospital and Beijing Chao-yang Hospital, Capital Medical University from January to March 2014 were retrospectively analyzed. The baseline data of patients was collected, CCA-IMT and cfPWV before follow-up were measured. MHD patients were followed-up for 85 months, survival of patients was recorded, and patients were divided into survival group (36 cases) and death group (55 cases); according to CCA-IMT, patients were divided into CCA-IMT thickening group (43 cases, ≥0.9 mm)and CCA-IMT normal group (48 cases, <0.9 mm); according to cfPWV, patients were divided into cfPWV elevating group (37 cases, ≥12 m/s)and cfPWV normal group (54 cases, <12 m/s). The risk factors of all-cause death and cardiocerebral death in MHD patients were analyzed. Results The age, diabetic nephropathy (DN) rate, high-sensitivity C-reactive protein level, serum ferritin level and CCA-IMT in the death group were higher than those in the survival group(all P<0.05). Kaplan-Meier survival curve analysis showed that the rates of all-cause death and cardiocerebral death in the CCA-IMT thickening group were higher than those in the CCA-IMT normal group(both Log-rank P<0.001); the rates of all-cause death and cardiocerebral death in the cfPWV elevating group were higher than those in the cfPWV normal group (Log-rank P=0.017, 0.025). Multivariate Cox regression analysis showed that age [hazard ratio (HR)=1.035, 95% confidence interval (CI): 1.005-1.066, P=0.023], DN (HR=3.497, 95%CI: 1.886-6.485, P<0.001), CCA-IMT≥0.9 mm (HR=2.077, 95%CI: 1.114-3.872, P=0.021) and serum ferritin (HR=1.001, 95%CI: 1.000-1.002, P=0.019) were independent risk factors for all-cause death in MHD patients; DN (HR=2.632, 95%CI: 1.202-5.765, P=0.016), CCA-IMT≥0.9 mm (HR=6.261, 95%CI: 2.611-15.010, P<0.001) and cfPWV≥12 m/s (HR=2.644, 95%CI: 1.253-5.577, P=0.011) were independent risk factors for cardiocerebral death in MHD patients. Conclusion CCA-IMT and cfPWV elevating are independent risk factors for long-term all-cause death and cardiocerebral death in MHD patients.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。